APA (7th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. (2019). CADTH Canadian drug expert committee recommendation (final): Indication : treatment of adult patients with moderate-to severe plaque psoriasis who are candidates for systemic therapy. Certolizumab pegol (Cimzia -- UCB Canada Inc.). Canadian Agency for Drugs and Technologies in Health.

Chicago Style (17th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Recommendation (final): Indication : Treatment of Adult Patients with Moderate-to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy. Certolizumab Pegol (Cimzia -- UCB Canada Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019.

MLA (9th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Recommendation (final): Indication : Treatment of Adult Patients with Moderate-to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy. Certolizumab Pegol (Cimzia -- UCB Canada Inc.). Canadian Agency for Drugs and Technologies in Health, 2019.